Zhijun Hu

Shanghai Jiao Tong University, Renji Hospital

Papers

2

Total Citations

114

H-Index

2

About

Zhijun Hu is a leading gynecologic oncologist whose research has fundamentally advanced the surgical management of early-stage cervical cancer. His primary focus lies in fertility-sparing oncology, particularly the comparative effectiveness of radical trachelectomy techniques. Dr. Hu’s most impactful contributions come from the International Radical Trachelectomy Assessment Study (IRTA), a landmark collaborative investigation that systematically compared open versus minimally invasive radical trachelectomy outcomes. The IRTA study, published in 2019 and cited 53 times, established critical benchmarks for surgical safety and oncologic efficacy. Its follow-up analysis in 2021, which garnered 61 citations, provided definitive evidence on recurrence patterns and pregnancy outcomes, directly influencing clinical guidelines worldwide. By demonstrating that minimally invasive approaches offer comparable oncologic safety to open surgery while preserving fertility, Dr. Hu’s work has empowered thousands of young women with cervical cancer to pursue both curative treatment and future childbearing. His rigorous, multi-institutional methodology has set a new standard for evidence-based practice in gynecologic oncology, making him a pivotal figure in the evolution of fertility-preserving cancer surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
114
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study
61 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: Shanghai Jiao Tong University, Renji Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago